Volume 20, Number 1—January 2014
Research
Progenitor “Mycobacterium canettii” Clone Responsible for Lymph Node Tuberculosis Epidemic, Djibouti
Table 2
Cluster | Strain | No. spacers | Allele code† | Alias‡ (accession no.) |
---|---|---|---|---|
A | Percy3 and all other clone A strains | 26 | III-A-69@94 | STB-D CIPT140060008 (NC_019950) |
C | Percy1004 | 12 | III-A-69@74-95-96-89@91-94 | |
C | Percy32 | 30 | III-A-69@74-95@98-75@91-94 | |
C | CIPT140010059 | 29 | III-A-69@74-95@98-75@91-94 | STB-A CIPT140010059 (NC_015848) |
– | Percy79 | 31 | III-A-99@129 | |
– | Percy301 | 31 | III-A-99@129 | |
B | Percy214 | 8 | I-C-130@137 | STB-H CIPT140070013 |
B | Percy525 | 8 | I-C-130@137 | |
C | Percy1101 | 14 | I-C-130@143 | |
– | Percy25 | 7 | I-C-131-132-144@148 | STB-E CIPT140070002 |
– | Percy65 | 27 (1 doublet) | I-C-201@205-203-206@226 | STB-J CIPT140070017 (NC_019952) |
– | Percy327 | 9 | I-C-130-133@137-198@200 | STB-L CIPT140070008 (NC_019965) |
– | Percy302 | 50; 53 | I-C-149@191-178var-192@197;I-Cvar-337@389 | STB-K CIPT140070010 (NC_019951) |
– | Percy89 | 83 | I-E-228-230@232-88var-233@240-245@258-278@333 | STB-G CIPT140070005 |
– | Percy99b | 58 | I-E-227@232-88var-233 @280-334@336 | STB-I CIPT140070007 |
– | Percy157 | 52 | I-E-227@232-88var-233@277 |
*CRISPR, clustered regularly interspaced short palindromic repeats.
†The CRISPR type is indicated as prefix (type III-A, I-C, I-Cvar, I-E). Allele codes refer to the spacers dictionary (Technical Appendix 2 Table 1). "69@94" indicates that all spacers from 69 to 94 are present. Spacers 1 to 68 have been previously reported in M. tuberculosis (9). Spacer numbering in "M. canettii" runs from 69 up to 389, i.e., the total number of spacers observed in M. canettii is 321.
‡Strains sequenced by (5) as draft or completed (European Nucleotide Archive accession no. indicated) genome 88var = TCCAGAGGTCGAAGTGATGTTCGGTGTTCTCCT.
Page created: January 03, 2014
Page updated: January 03, 2014
Page reviewed: January 03, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.